NL8301980A - Factoren 1,2,3,4, en 5 van teichomycine a2 en werkwijze voor de bereiding daarvan. - Google Patents

Factoren 1,2,3,4, en 5 van teichomycine a2 en werkwijze voor de bereiding daarvan. Download PDF

Info

Publication number
NL8301980A
NL8301980A NL8301980A NL8301980A NL8301980A NL 8301980 A NL8301980 A NL 8301980A NL 8301980 A NL8301980 A NL 8301980A NL 8301980 A NL8301980 A NL 8301980A NL 8301980 A NL8301980 A NL 8301980A
Authority
NL
Netherlands
Prior art keywords
nujol
teichomycin
factor
acetonitrile
water
Prior art date
Application number
NL8301980A
Other languages
English (en)
Dutch (nl)
Original Assignee
Lepetit Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit Spa filed Critical Lepetit Spa
Publication of NL8301980A publication Critical patent/NL8301980A/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/045—Actinoplanes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Fodder In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NL8301980A 1982-06-08 1983-06-03 Factoren 1,2,3,4, en 5 van teichomycine a2 en werkwijze voor de bereiding daarvan. NL8301980A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8216590 1982-06-08
GB8216590 1982-06-08

Publications (1)

Publication Number Publication Date
NL8301980A true NL8301980A (nl) 1984-01-02

Family

ID=10530888

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8301980A NL8301980A (nl) 1982-06-08 1983-06-03 Factoren 1,2,3,4, en 5 van teichomycine a2 en werkwijze voor de bereiding daarvan.

Country Status (32)

Country Link
US (1) US4542018A (no)
JP (5) JPS591423A (no)
KR (1) KR900008246B1 (no)
AU (1) AU560966B2 (no)
BE (1) BE896993A (no)
BG (1) BG60529B2 (no)
CA (1) CA1208204A (no)
CH (1) CH657139A5 (no)
DE (1) DE3320342A1 (no)
DK (1) DK159117C (no)
ES (2) ES8503689A1 (no)
FI (1) FI73697C (no)
FR (1) FR2528050B1 (no)
GB (1) GB2121401B (no)
GR (1) GR78267B (no)
HK (1) HK55887A (no)
HU (1) HU193538B (no)
IE (1) IE55025B1 (no)
IL (1) IL68819A0 (no)
IT (1) IT1212085B (no)
LU (1) LU84853A1 (no)
MY (1) MY8700002A (no)
NL (1) NL8301980A (no)
NO (1) NO159104C (no)
NZ (1) NZ204480A (no)
PH (1) PH19533A (no)
PT (1) PT76831B (no)
SE (1) SE459094B (no)
SG (1) SG70686G (no)
SU (1) SU1318170A3 (no)
UA (1) UA6025A1 (no)
ZA (1) ZA833607B (no)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8307847D0 (en) * 1983-03-22 1983-04-27 Lepetit Spa Antibiotics l 17054 and l 17046
US4696817A (en) * 1983-10-11 1987-09-29 The Dow Chemical Company Extraction of teichomycin A2 from whole culture fermentation broth
GB8333624D0 (en) * 1983-12-16 1984-01-25 Lepetit Spa Antibiotics l 17054 and l 17392
GB8415093D0 (en) * 1984-06-13 1984-07-18 Lepetit Spa Antibiotic l 17392
GB8415092D0 (en) * 1984-06-13 1984-07-18 Lepetit Spa Ester derivatives
GB8428619D0 (en) * 1984-11-13 1984-12-19 Lepetit Spa Derivatives of antibiotic l 17046
GB8512795D0 (en) * 1985-05-21 1985-06-26 Lepetit Spa Increasing ratio of components of teicoplanin a2 complex
US4694069A (en) * 1985-09-30 1987-09-15 Smithkline Beckman Corporation Kibdelosporangium aridum SK&F-AAD-609
JPS61241319A (ja) * 1986-04-25 1986-10-27 Kanegafuchi Chem Ind Co Ltd 新規エーテル‐エステルブロツク共重合体を含有する室温硬化性組成物
US4845194A (en) * 1987-02-27 1989-07-04 Eli Lilly And Company Glycopeptide recovery process
GB8715735D0 (en) * 1987-07-03 1987-08-12 Lepetit Spa De-mannosyl teicoplanin derivatives
US4996148A (en) * 1987-07-13 1991-02-26 Eli Lilly And Company A80407 antibiotics
US5213797A (en) * 1987-07-13 1993-05-25 Eli Lilly And Company A80407 antibiotics
GB8720980D0 (en) * 1987-09-07 1987-10-14 Lepetit Spa Derivatives
US5194424A (en) * 1988-12-27 1993-03-16 Gruppo Lepetit Spa C63 -amide derivatives of 34-de(acetylglucosaminyl)-34-deoxy-teicoplanin and their use as medicaments against bacteria resistant to glycopeptide antibiotics
WO1992010516A1 (en) * 1990-12-05 1992-06-25 Gruppo Lepetit S.P.A. 38-decarboxy-38-hydroxymethyl derivatives of teicoplanin antibiotics, and a process for preparing them
US5606036A (en) * 1991-03-27 1997-02-25 Gruppo Lepetit Spa Antibiotic A 40926 ester derivatives
CA2250578C (en) 1996-04-23 2003-06-24 Versicor Inc. Improved chemical process for preparing amide derivatives of antibiotic a 40926
KR100476818B1 (ko) * 2002-07-19 2005-03-17 종근당바이오 주식회사 테이코플라닌 에이 투 정제 방법
US7119061B2 (en) 2002-11-18 2006-10-10 Vicuron Pharmaceuticals, Inc. Dalbavancin compositions for treatment of bacterial infections
US20060074014A1 (en) 2002-11-18 2006-04-06 Vicuron Pharmaceuticals Inc. Dalbavancin compositions for treatment of bacterial infections
DK1565201T3 (en) 2002-11-18 2019-02-25 Vicuron Pharmaceuticals Llc METHODS OF ADMINISTRATING DALBAVANCIN TO TREAT Bacterial Infections
EP1806150A1 (en) * 2006-01-05 2007-07-11 NEED PHARMA S.r.l. Teicoplanin composition
CN102718843B (zh) * 2012-06-30 2014-05-14 华北制药集团新药研究开发有限责任公司 一种替考拉宁单组份的制备方法
CN114112612A (zh) * 2021-10-28 2022-03-01 丽珠集团福州福兴医药有限公司 一种替考拉宁i5杂质的分离纯化方法及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1496386A (en) * 1975-03-05 1977-12-30 Lepetit Spa Antibiotics

Also Published As

Publication number Publication date
NO159104C (no) 1988-11-30
GR78267B (no) 1984-09-26
JPS591423A (ja) 1984-01-06
FI831660A0 (fi) 1983-05-12
ES536770A0 (es) 1985-08-16
ES8506748A1 (es) 1985-08-16
JPH0415237B2 (no) 1992-03-17
DK159117C (da) 1991-02-11
MY8700002A (en) 1987-12-31
JPH0517237B2 (no) 1993-03-08
FI831660L (fi) 1983-12-09
JPH02288887A (ja) 1990-11-28
JPH0517236B2 (no) 1993-03-08
PT76831A (en) 1983-07-01
JPH0224278B2 (no) 1990-05-29
SE8303211L (sv) 1983-12-09
GB2121401B (en) 1985-09-18
DK159117B (da) 1990-09-03
NO831754L (no) 1983-12-09
BG60529B2 (bg) 1995-07-28
DK245883A (da) 1983-12-09
NO159104B (no) 1988-08-22
SE8303211D0 (sv) 1983-06-07
GB2121401A (en) 1983-12-21
IT8321432A0 (it) 1983-06-02
UA6025A1 (uk) 1994-12-29
ES522941A0 (es) 1985-04-01
IL68819A0 (en) 1983-09-30
JPH02288888A (ja) 1990-11-28
ZA833607B (en) 1984-03-28
AU560966B2 (en) 1987-04-30
BE896993A (fr) 1983-12-07
JPH02291278A (ja) 1990-12-03
GB8315003D0 (en) 1983-07-06
PT76831B (en) 1986-04-09
HK55887A (en) 1987-08-07
FI73697C (fi) 1987-11-09
SU1318170A3 (ru) 1987-06-15
DK245883D0 (da) 1983-05-31
JPH02291279A (ja) 1990-12-03
US4542018A (en) 1985-09-17
KR840005170A (ko) 1984-11-05
AU1496883A (en) 1983-12-15
FR2528050A1 (fr) 1983-12-09
DE3320342A1 (de) 1983-12-08
NZ204480A (en) 1986-04-11
DE3320342C2 (no) 1991-07-11
CA1208204A (en) 1986-07-22
ES8503689A1 (es) 1985-04-01
LU84853A1 (fr) 1984-03-07
JPH0415238B2 (no) 1992-03-17
FI73697B (fi) 1987-07-31
IE831329L (en) 1983-12-08
CH657139A5 (fr) 1986-08-15
IE55025B1 (en) 1990-04-25
IT1212085B (it) 1989-11-08
SG70686G (en) 1987-07-03
FR2528050B1 (fr) 1987-03-20
PH19533A (en) 1986-05-20
HU193538B (en) 1987-10-28
SE459094B (sv) 1989-06-05
KR900008246B1 (ko) 1990-11-06

Similar Documents

Publication Publication Date Title
NL8301980A (nl) Factoren 1,2,3,4, en 5 van teichomycine a2 en werkwijze voor de bereiding daarvan.
KR910008626B1 (ko) 항생물질 l 17054의 순수 제제의 제조 방법
KR960012063B1 (ko) 글리콜펩티드 항생물질 pa-45052 및 그의 제조방법
JPH04217988A (ja) 抗生物質ｇｅ２２７０因子ｂ１、ｂ２、ｃ１、ｃ２、ｄ１、ｄ２、ｅおよびｔ
JP3122248B2 (ja) 抗生物質ＧＥ２２７０因子Ｃ２ａ
AU2003252851A1 (en) Reversible boronate complexes of 1,2-cis-diol cyclic-peptides
EP1130027A1 (de) Memno-Peptide, Verfahren zu ihrer Herstellung und Verwendung derselben
JPH10120563A (ja) 免疫抑制剤
WO1998052596A1 (en) Glycopeptide hexapeptides
JP2016501232A (ja) 新規ランチビオティック誘導体およびその調製プロセス
EP0369503B1 (en) Method for the control of pneumocystis carinii
EP0326029B1 (en) Antibiotic A 42867 derivative
JPH07114704B2 (ja) 抗生物質ａ４２８６７およびその付加塩
JPH0430400B2 (no)
HU193905B (en) Process for preparing glycopeptide antibiotics by means of bioconversion
US4264736A (en) Antibiotic 890A10
JPH01240196A (ja) 新規グリコペプチド系抗生物質ｐａ−４５０５２
US4264735A (en) Method of producing antibiotic 890A9
JPH03191788A (ja) 新規抗生物質ｎｋ１５５１４１およびその製造法
JPH0776595A (ja) サルマイシン、その製造方法及び医薬としてのその使用
JPH03197489A (ja) 抗生物質ｔａｎ―１１７１およびその製造法
JP2003113192A (ja) 抗生物質ｗａｐ−２６０７ｂ、その製造法及び抗菌剤

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
CNR Transfer of rights (patent application after its laying open for public inspection)

Free format text: AVENTIS BULK S.P.A.

BN A decision not to publish the application has become irrevocable